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Despite significant advances in the management of acute
myocardial infarction, it remains a major cause of morbidity
and mortality. After myocardial infarction, viable myocardi-
um is lost and is replaced by fibrotic tissue. This increases the
tensile strength of the infarcted myocardium preventing car-
diac rupture. However, ultimately it impairs the contractile
capacity of the heart leading to heart failure.
For several years, cell transplantation has been employed in
the damaged heart of patients with end-stage heart failure. The
aim of cell transplantation is to improve cardiac function.
Indeed, to this point clinical trials show a modest therapeutic
effect of cardiac cell therapy on cardiac function. The positive
effects of cell therapy are believed to be mainly mediated by
paracrine factors excreted by the transplanted cells. The role of
direct cardiomyogenic or angiogenic differentiation of the
transplanted cells that have been used in the clinical trials is
thought to be small. Furthermore, pre-clinical studies have
shown that only low percentages of injected cells survive
and engraft in the infarcted myocardium. This finding could
explain the modest effects that have been observed in both
pre-clinical and clinical studies. Several studies are therefore
aiming to improve stem cell survival and engraftment (e.g. by
using biomaterials). Besides improving cell survival and en-
graftment, a better selection of the location of cell injection
may also influence the therapeutic effect of such therapy. In
the study by Van Slochteren et al. a 3D Cardbox image
registration toolbox is used which makes it possible to stan-
dardise the transplantation location.[1] In this study, the re-
searchers aimed to transplant stem cells in the 50 % infarct
transmurality border zone. It is expected that in this area the
stem cells are able to exert their therapeutic effects, while not
being deprived of oxygen and nutrients. Indeed, it is known
that the physiological niche of bone marrow-derived mesen-
chymal stem cells, frequently studied for cardiac cell
therapy, has a low oxygen tension. Furthermore, several
studies have shown that hypoxia enhanced the tissue
regenerative potential of bone marrow-derived mesen-
chymal stem cells.[2, 3] Injection of stem cells in the
correct location is therefore of importance to obtain the
maximum therapeutic effect, which makes the results of
this study highly relevant.
The positive effect of cell therapy is also thought to be
dependent on cell-to-cell contact. In a recent study it was
shown that gap junctional coupling, which is essential in
electrochemical communication between cardiomyocytes, is
also a key factor in inducing cardiomyogenic differentiation
of mesenchymal stem cells. After downregulation of
connexin43, themajor gap junction protein in themyocardium,
cardiomyogenic differentiation of the stem cells was
prevented. By overexpressing connexin45 and thereby restor-
ing the ability to respond to cardiomyogenic stimuli provided
by neighbouring cardiomyocytes, the cardiomyogenic differ-
entiation potential of the mesenchymal stem cells was
restored.[4] The injection at location defined by the study by
Van Slochteren et al . [1] makes interaction with
cardiomyocytes possible and may therefore increase the ther-
apeutic potential of cardiac cell therapy. To our knowledge,
cardiomyogenic differentiation of mesenchymal stem cells that
were only adjacent to cardiac fibroblasts was never observed in
pre-clinical studies. Whether the excretion of paracrine factors
that are involved in regeneration of the infarcted myocardium
also depends on the interaction of cardiomyocytes with stem
cells, has not yet been investigated [5].
By employing techniques that allow more precise and
standardised selection of the target location for cell
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transplantation, the retention of stem cells in the targeted area
may also improve by favouring survival and engraftment. An
increase in the retention of stem cells may lead to an increase
in the occurrence of arrhythmias. The occurrence of arrhyth-
mias was not studied in the study by Van Slochteren et al.[1]
While they show an elegant way to improve injection at the
correct location, the engraftment pattern of the stem cells is
not controlled by using the 3D Cardbox. In a recent study by
Askar et al., the effects of these abovementioned factors,
engraftment number and pattern, were shown to be related to
the occurrence of arrhythmias.[6] Further investigation is
therefore needed to fully understand the role of the 3D
Cardbox in optimising cardiac regeneration by stem cell
transplantation.
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